Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHF 1535 in partly controlled asthmatic children
NCT01475032Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Sep 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of beclomethasone dipropionate, formoterol in asthma, sponsored by Chiesi Farmaceutici S.p.A.. Started Sep 2011; status: completed.
02
Drugs
beclomethasone dipropionateformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01475032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01475032.